Literature DB >> 19112790

Recovery and functional activity of mononuclear bone marrow and peripheral blood cells after different cell isolation protocols used in clinical trials for cell therapy after acute myocardial infarction.

Rachel T van Beem1, Alexander Hirsch, Ingrid M Lommerse, Jaap Jan Zwaginga, Willy A Noort, Bart J Biemond, Jan J Piek, C Ellen van der Schoot, Carlijn Voermans.   

Abstract

AIMS: Clinical trials showed contradictory results in functional recovery after intracoronary infusion of autologous mononuclear (bone marrow) cells in patients with acute myocardial infarction. A recent study suggests that this might be related to the isolation protocol used. In The Netherlands, a comparable randomised multicentre trial (HEBE) was designed. To validate the isolation method of bone marrow and peripheral blood-derived mononuclear cells, we compared our processing protocol with methods comparable to the ASTAMI (no beneficial effect) and the REPAIR-AMI study (beneficial effect). METHODS AND
RESULTS: The effect of several factors (density gradient, washing buffer and centrifugation speed) has been studied on recovery and function (migration and clonogenic capacity) of mononuclear cells. Significantly lower cell recoveries were found at a centrifugation speed of 250 g, compared to 600 or 800 g, respectively. Furthermore, washing buffer without supplemented human serum albumin and heparin resulted in significantly lower cell recovery and functional impairment as measured by clonogenic capacity.
CONCLUSIONS: The results of our study justify the cell-processing protocol as applied in the HEBE trial (600 g, human serum albumin supplemented washing buffer). This protocol results in viable and functional cells of which the quantity and quality is at least comparable to a successful study like the REPAIR-AMI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112790     DOI: 10.4244/eijv4i1a21

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  10 in total

1.  Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results.

Authors:  A van der Laan; A Hirsch; R Nijveldt; P A van der Vleuten; W J van der Giessen; P A Doevendans; J Waltenberger; J M Ten Berg; W R M Aengevaeren; J J Zwaginga; B J Biemond; A C van Rossum; J G P Tijssen; F Zijlstra; J J Piek
Journal:  Neth Heart J       Date:  2008-12       Impact factor: 2.380

2.  Single-step enrichment of basophils from human peripheral blood by a novel method using a Percoll density gradient.

Authors:  Hiroyuki Shiono; Takuya Matsui; Tadashi Okada; Yoichiro Ito
Journal:  J Sep Sci       Date:  2016-08       Impact factor: 3.645

3.  Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.

Authors:  Jay H Traverse; Timothy D Henry; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; John R Forder; Barry J Byrne; Antonis K Hatzopoulos; Marc S Penn; Emerson C Perin; Kenneth W Baran; Jeffrey Chambers; Charles Lambert; Ganesh Raveendran; Daniel I Simon; Douglas E Vaughan; Lara M Simpson; Adrian P Gee; Doris A Taylor; Christopher R Cogle; James D Thomas; Guilherme V Silva; Beth C Jorgenson; Rachel E Olson; Sherry Bowman; Judy Francescon; Carrie Geither; Eileen Handberg; Deirdre X Smith; Sarah Baraniuk; Linda B Piller; Catalin Loghin; David Aguilar; Sara Richman; Claudia Zierold; Judy Bettencourt; Shelly L Sayre; Rachel W Vojvodic; Sonia I Skarlatos; David J Gordon; Ray F Ebert; Minjung Kwak; Lemuel A Moyé; Robert D Simari
Journal:  JAMA       Date:  2011-11-14       Impact factor: 56.272

Review 4.  Oxygen and oxygenation in stem-cell therapy for myocardial infarction.

Authors:  Mahmood Khan; Pawel Kwiatkowski; Brian K Rivera; Periannan Kuppusamy
Journal:  Life Sci       Date:  2010-06-28       Impact factor: 5.037

5.  Density gradient centrifugation compromises bone marrow mononuclear cell yield.

Authors:  Claudia Pösel; Karoline Möller; Wenke Fröhlich; Isabell Schulz; Johannes Boltze; Daniel-Christoph Wagner
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

Review 6.  Benchtop technologies for circulating tumor cells separation based on biophysical properties.

Authors:  Wan Shi Low; Wan Abu Bakar Wan Abas
Journal:  Biomed Res Int       Date:  2015-04-21       Impact factor: 3.411

Review 7.  The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy.

Authors:  Xianyun Wang; Jun Zhang; Fan Zhang; Jing Li; Yaqi Li; Zirui Tan; Jie Hu; Yixin Qi; Quanhai Li; Baoyong Yan
Journal:  Stem Cells Int       Date:  2015-05-26       Impact factor: 5.443

8.  Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.

Authors:  Sreeraj G Pillai; Peixuan Zhu; Chidananda M Siddappa; Daniel L Adams; Shuhong Li; Olga V Makarova; Pete Amstutz; Ryan Nunley; Cha-Mei Tang; Mark A Watson; Rebecca L Aft
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

9.  Quantitative Assessment of Optimal Bone Marrow Site for the Isolation of Porcine Mesenchymal Stem Cells.

Authors:  J S McDaniel; B Antebi; M Pilia; B J Hurtgen; S Belenkiy; C Necsoiu; L C Cancio; C R Rathbone; A I Batchinsky
Journal:  Stem Cells Int       Date:  2017-04-30       Impact factor: 5.443

10.  Tissue evacuated during joint replacement procedure as a source of mononuclear cells.

Authors:  Jakobsons Eriks; Erglis Kristaps; Patetko Liene; Erglis Martins; Rasma Dortane; Beatrise Rupaine; Simona Krapse; Briede Ieva; Valdis Goncars; Muiznieks Indrikis; Erglis Andrejs
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.